🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 8 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
14/07/2017 1,57 1,59 1,51 1,52 -2,56% 5,10% 291.800
13/07/2017 1,55 1,58 1,50 1,56 +0,00% 5,16% 469.200
12/07/2017 1,55 1,58 1,53 1,56 +1,96% 3,23% 466.100
11/07/2017 1,56 1,57 1,50 1,53 -1,92% 4,49% 533.300
10/07/2017 1,62 1,62 1,52 1,56 -3,70% 6,17% 792.700
07/07/2017 1,62 1,67 1,60 1,62 +1,25% 4,01% 352.900
06/07/2017 1,66 1,72 1,60 1,60 -4,19% 7,23% 312.500
05/07/2017 1,65 1,72 1,64 1,67 +1,21% 5,15% 635.600
03/07/2017 1,64 1,68 1,61 1,65 +1,85% 4,27% 273.300
30/06/2017 1,57 1,63 1,57 1,62 +2,53% 3,82% 421.900
29/06/2017 1,63 1,65 1,57 1,58 -3,07% 4,91% 516.900
28/06/2017 1,59 1,67 1,57 1,63 +2,52% 6,29% 921.800
27/06/2017 1,58 1,68 1,58 1,59 +0,00% 6,33% 1.007.900
26/06/2017 1,59 1,63 1,55 1,59 +2,58% 5,03% 2.164.600
23/06/2017 1,71 1,80 1,55 1,55 -10,40% 14,62% 9.124.900
22/06/2017 1,79 1,90 1,73 1,73 -1,70% 9,50% 1.208.300
21/06/2017 1,64 1,87 1,60 1,76 +7,98% 16,16% 1.650.300
20/06/2017 1,65 1,68 1,60 1,63 -1,21% 4,85% 521.900
19/06/2017 1,59 1,67 1,55 1,65 +3,77% 7,55% 551.000
16/06/2017 1,64 1,68 1,55 1,59 -5,36% 7,93% 654.000
15/06/2017 1,60 1,69 1,58 1,68 +4,35% 6,87% 445.300
14/06/2017 1,57 1,62 1,53 1,61 +2,55% 5,73% 294.100
13/06/2017 1,57 1,64 1,56 1,57 -0,63% 4,90% 339.300
12/06/2017 1,64 1,64 1,56 1,58 -2,47% 5,18% 427.400
09/06/2017 1,59 1,67 1,56 1,62 +0,62% 6,92% 331.700
08/06/2017 1,63 1,69 1,57 1,61 -2,42% 7,36% 334.200
07/06/2017 1,67 1,73 1,65 1,65 +0,00% 5,09% 469.400
06/06/2017 1,53 1,66 1,53 1,65 +5,77% 8,17% 324.600
05/06/2017 1,52 1,61 1,52 1,56 -3,70% 5,92% 411.500
02/06/2017 1,54 1,64 1,54 1,62 +5,88% 6,49% 494.200